Markets-Desk·im Tagesverlauf aktualisiert
Märkte/AktienArtikel

European Shares Close Lower as Markets Slide Ahead of Anthropic IPO

European stock markets extended their downward trend on Thursday, weighed down by falling US exchanges and defensive heavyweight losses ahead of Anthropic's public debut.

Redaktion Helvetic Markets · 20 Nov 2026 · 06:00 · 1 Min. Lesezeit
Teilen
European Shares Close Lower as Markets Slide Ahead of Anthropic IPO
Photo: Rômulo Queiroz / Pexels

Europe's major stock markets extended their downward trend on Thursday. Pulled down by weakening US exchanges, the EuroStoxx 50 closed 0.66 percent lower at 6,113.86 points. Zurich's SMI fell a further 1.10 percent to 14,721.84 points, pressured by price declines in defensive heavyweights such as Novartis and Nestlé. London's FTSE 100 declined 0.93 percent to 10,452.68 points.

Anticipation surrounding the imminent initial public offering of artificial intelligence company Anthropic faded on both sides of the Atlantic, even before its opening price was determined in New York. Pricing was recently shaping up well above the issue price of 83 US dollars. Investors may have also withdrawn funds from other equities to participate in the anticipated Anthropic share rally.

A successful debut could strengthen confidence in multibillion-dollar investments in AI infrastructure, according to market analyst Andreas Lipkow from broker CMC Markets. Conversely, if the stock comes under pressure after trading begins, investors are likely to view the valuations and investment strategies of major technology companies more critically.

Across the broad Stoxx Europe 600 sectors, there were only losers on Thursday. The little-moved technology index held up best, with shares of chip supplier ASML gaining 2.2 percent to lead the EuroStoxx. Industrial stocks, considered beneficiaries of the artificial intelligence boom, also lost comparatively little. However, a capital increase feared by analysts caused Alstom shares to drop 4.3 percent, pushing the stock to a record low.

Defensive food and beverage manufacturers, alongside healthcare companies, came under the heaviest pressure. Novartis shares lost 3.2 percent after the pharmaceutical giant revised its medium-term growth targets, anticipating higher sales for some key products. Analysts had expected this, however, and had hoped for more regarding margin development. At competitor Sanofi, reported interest in US biotech company Insmed triggered a 2.9 percent share price drop.

Quelle: cash.ch — All News

Dieser Artikel wurde vom Markets-Desk von Helvetic Markets mit KI-Unterstützung erstellt.
Artikel teilen